FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance

Jul.30

FDA Commissioner Robert Califf urged the DEA to classify 7-OH, an opioid-like compound found in vapes, drinks, and gummies, as a Schedule I substance. The FDA plans national warnings for doctors and tighter control of high concentrations.

Key points:

·FDA recommends: FDA Commissioner Marty Makary announced that 7-hydroxymitragynine (7-OH) will be classified as a controlled substance due to its opioid-like properties.

·Widespread availability: 7-OH can be found in e-cigarette stores, beverages, and children's gummies.

·Regulatory measures: FDA recommends that 7-hydroxymitragynine above a certain concentration threshold be classified as a Schedule I controlled substance.

·Public education: FDA has issued a report and warned healthcare providers, emphasizing the risks of abuse associated with 7-OH.

【2Firsts News Flash】On July 30th, according to Reuters, Marty Makary, director of the FDA, suggested that 7-hydroxymitragynine (7-OH) be classified as a controlled substance due to its opiate-like properties.

He stated at a press conference held at the Department of Health and Human Services in Washington D.C. that many products containing 7-OH are sold in e-cigarette stores, and this compound is also present in beverages and children's gummy candies.

The FDA's letter to the DEA will recommend classifying 7-OH above a certain concentration threshold as a Schedule I controlled substance.

The FDA stated that the abuse potential of 7-OH is increasingly being scrutinized due to its ability to bind to opioid receptors.

"It is sold in e-cigarette shops, tobacco shops, convenience stores, and gas stations across the United States," said Macari.

The FDA is in the process of releasing a report and sending warning letters to every doctor in America. Markari stated that the FDA will continue its efforts to educate the public.

References:

[1] FDA recommends 7-OH compound found in vapes be controlled

Also Read:

[1] U.S. Fourth Circuit Court Rules North Carolina Can Ban Sale of FDA-Unapproved E-Cigarette Products

[2] U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Following Japan debut, IQOS ILUMA i “Seletti Edition” limited series launches in South Korea.

Philip Morris International (PMI) Korea announced a collaboration with Italian design brand Seletti to launch the IQOS ILUMA i limited “Seletti Edition.” Pre-sales begin on the 29th at IQOS.com for IQOS Club Gold and Platinum members, with sales from the 30th via the website and nine IQOS-owned stores nationwide. PMI previously said the series would debut in Japan first before rolling out to 13 global travel-retail markets.

Oct.29 by 2FIRSTS.ai

Spanish Police Seize Over 24,000 Smuggled E-Cigarettes; Two Arrested on Multiple Charges

The Spanish Civil Guard carried out an operation targeting e-cigarette smuggling and illegal distribution, seizing a total of 24,520 e-cigarettes of unknown origin valued at approximately €312,000.

Oct.10 by 2FIRSTS.ai

China Qingdao Jiaodong Airport Customs Seizes 430 Disposable E-Cigarettes and 8600ml of E-Liquid

Qingdao Jiaodong Airport customs seized 430 disposable e-cigarettes with 8600ml e-liquid, exceeding personal duty-free limits. Items detained for legal processing.

Oct.14 by 2FIRSTS.ai

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

Verkhovna Rada is reviewing six bills to regulate new nicotine products such as pouches and vapes. The main bill, No.14110, proposes a total ban on production, import, and sale, while alternative proposals seek regulation instead of prohibition.